Cancer Check Labs, a leader in advanced cancer detection, is proud to announce its expansion into the Canadian market through an exclusive partnership with Healthcode Medical. This collaboration aims to make early cancer detection more accessible to Canadians, empowering individuals to take proactive steps in safeguarding their health.
Cancer is a leading cause of death in Canada, with 1 in 2 Canadians projected to face a diagnosis in their lifetime. In 2023 alone, over 200,000 new cases were reported, underscoring the critical importance of early detection. Advanced screenings have proven to significantly improve survival rates and the quality of life for patients.
“Cancer Check Labs is on a mission to save lives through early detection,” said Sumit Rai, CEO of Cancer Check Labs. “By partnering with Healthcode Medical, we can deliver our innovative testing solutions to Canadians, helping them take control of their health and create more meaningful moments with loved ones.”
The partnership with Healthcode Medical aligns seamlessly with its vision of offering leading-edge healthcare solutions. Healthcode is renowned for its emphasis on prevention, early detection, and personalized health optimization.
“We’re excited to join forces with Cancer Check Labs to enhance access to advanced cancer screenings,” said Dr. Jan Venter, Medical Director of Healthcode Medical. “This partnership is about giving Canadians the tools they need to catch cancer early, so they can continue to celebrate life’s milestones—birthdays, graduations, and family gatherings.”
Together, Cancer Check Labs and Healthcode Medical work to emphasize the importance of early detection while providing access to state-of-the-art testing technologies. Their goal is to empower Canadians with the knowledge and resources needed to live healthier, fuller lives.
About Cancer Check Labs Headquartered in Dallas, Texas, Cancer Check Labs specializes in early cancer detection by isolating whole, intact circulating tumor cells (CTCs) from blood samples. Their groundbreaking technology can detect cancer as early as Stage 0, making it one of the most advanced cancer screening tools available today.